Company profile: Vesper Medical
1.1 - Company Overview
Company description
- Provider of venous stenting solutions for deep venous disease, centered on the purpose-built Vesper DUO Venous Stent System, a portfolio of self-expanding nitinol stents to improve luminal diameter in symptomatic venous outflow obstructions, including DUO-HYBRID and DUO-EXTEND, and the VIVID clinical trial evaluating safety and efficacy in iliofemoral occlusive disease.
Products and services
- DUO-EXTEND Stent: A modular, self-expanding open-cell nitinol stent engineered to integrate with the DUO-HYBRID stent, providing flexibility to treat longer lesions
- DUO-HYBRID Stent: An industrial-grade, self-expanding open-cell nitinol stent delivering high crush resistance and flexibility, architected to treat from the inferior vena cava to the common femoral vein
- Vesper DUO Venous Stent System: A custom-engineered portfolio of self-expanding venous stents that improves luminal diameter in symptomatic venous outflow obstructions, combining unmatched strength and flexibility, including DUO-HYBRID and DUO-EXTEND
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Vesper Medical
Omeicos
HQ: Germany
Website
- Description: Provider of first-in-class small-molecule therapeutics based on omega-3 fatty acid metabolites for the treatment and prevention of atrial fibrillation and broader indications. Offers OMT-28, a synthetic analog of 17,18-EEQ for cardiovascular inflammation and mitochondrial dysfunction; conducts the PMD-OPTION study in Primary Mitochondrial Disease; and develops a pipeline of proprietary omega-3 analogs for cardiovascular, inflammatory, and mitochondrial diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Omeicos company profile →
Second Heart Assist
HQ: United States
Website
- Description: Provider of minimally invasive circulatory support platforms using proprietary aortic stent pump technology, offering Whisper, a catheter-based assist pump for temporary support placed via the femoral artery, and Freedom, a wireless powered chronic implant for long-term circulatory support positioned above the renal arteries.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Second Heart Assist company profile →
XO1
HQ: United Kingdom
Website
- Description: Provider of virtual biotechnology development focused on ichorcumab, operating without offices or laboratories by engaging high-quality contract research and development specialists in Europe and the US, managed by a small team of experienced drug developers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full XO1 company profile →
RR Mechatronics
HQ: The Netherlands
Website
- Description: Provider of analytics laboratory instruments for the medical diagnosis industry.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full RR Mechatronics company profile →
TriVascular
HQ: United States
Website
- Description: Provider of new medical devices delivering optimal solutions for endovascular aortic repair (EVAR).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriVascular company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Vesper Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Vesper Medical
2.2 - Growth funds investing in similar companies to Vesper Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Vesper Medical
4.2 - Public trading comparable groups for Vesper Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →